There is increasing interest in the importance of pyridoxine in brain disorders of childhood. Con- vulsions have occurred in infants receiving a pyridoxine (vitamin B6) deficient diet (Coursin, 1955) , and Bessey, Adam, and Hansen (1957) have shown that some infants have a greater requirement than others for this vitamin. In the deficiency state, small amounts of vitamin B6 stop the convulsions, but greater than normal amounts are required to correct the increased xanthurenic acid excretion (Bessey et al., 1957) . In the dependency states (Scriver, 1960) described in sibs (Waldinger and Berg, 1963) , increased excretion of xanthurenic acid has not been a feature, though high doses of vitamin B6 are required to control convulsions.
In 1963, O'Brien and Jensen considered whether vitamin B6 dependency could be a causal factor in mentally retarded persons who did not have convulsions, and during the screening of a mental institution they found two women (aged 17 and 31 years) with evidence of vitamin B6 dependency. These authors suggested that the ratio of the concentrations of 3-hydroxykynurenine and 3-hydroxyanthranilic acid found in urine would be superior to the measurement of the excretion of xanthurenic acid as an indicator of vitamin B6 dependency. The value of this index has been described by Heeley (1965) , whose values for the index in normal children agree with those of Michael, Drummond, Doeden, Anderson, and Good (1964) .
Biochemical screening of mentally retarded children at The Hospital for Sick Children revealed two sibs who metabolized a tryptophan load abnormally at the pyridoxine-dependent kynureninase reaction. In addition, both sibs had raised levels of leucine in their sera.
Recent work by Belavady, Srikantia, and Gopalan (1963) has shown that high serum levels of leucine in man inhibit the katabolism of tryptophan via kynurenine at some point subsequent to quinolinic acid, resulting in the increased urinary excretion of the latter. Fig. 1 shows the metabolic pathways for the metabolism of tryptophan to nicotinic acid via quinolinic acid.
The purpose of the present investigation was to measure the excretion of quinolinic acid in the sibs, and thus to determine whether a second defect occurred along the metabolic pathway that synthesizes the nicotinamide co-enzymes from tryptophan.
The biochemical aspects of this investigation have been briefly reported elsewhere (Heeley and McCubbing, 1965).
Case Reports Case 1. L.H. weighed 3089 g. (6 lb. 13 oz.) at birth, and was delivered at full term by caesarean section for foetal distress, but no resuscitation was required.
Her early development was uneventful. She sat at 6 months, walked alone at 2 years, and said a few single words between 6 and 12 months. Thereafter she did not speak again until 4 years old, and then only single words. At 2 years she seemed to be short-sighted and she has worn glasses since the age of 3. She has never had any convulsions.
The parents first sought help because of her failure to talk. After the diagnosis of severe mental retardation (IQ 40) had been made, the child was admitted to The Hospital for Sick Children for further investigation at the age of 4 years 11 months.
In the ward she spent her time wandering around aimlessly and peering short-sightedly at people and things. She made frequent loud squealing noises but spoke no proper words, and never played with toys.
On examination she was just on the third centile for height and weight, but apart from severe myopia, nothing of note was found. During the next year, further improvement was much slower, and though both children were more cheerful and responsive compared with previously, the formal IQ of 35 to 40 before treatment did not change.
The abnormal EEG seen before treatment also showed marked improvement during the first 2 months of treatment, but thereafter there was no further change.
Biochemical Investigations
Tryptophan load tests. Investigations were performed during the initial admission to hospital and at varying intervals after the children were placed on daily supplements of 30 mg. pyridoxine.
The metabolites kynurenine (K), 3-hydroxykynurenine (HK), 3-hydroxyanthranilic acid (HA), quinolinic acid (QA), and xanthurenic acid (XA) were measured in urine collected for a period of 8 hours from the time of administration of an oral load of L-tryptophan (0 * 1 g./kg. body weight). Details of the oral loading procedure, urine collection, and analytical methods for K, HK, HA, and XA have been described (Heeley, 1965) .
The method used for the separation of QA from other urinary compounds is given in the Appendix.
Serum leucine, valine and iso-leucine. Capillary blood obtained by finger-prick was collected 2 hours after breakfast. The serum was desalted on an ion exchange resin column and the amino acids were separated, identified, and measured by a quantitative paper chromatographic technique (see Appendix).
Results of Biochemical Investigations
The results of routine biochemical investigations for the two sibs are shown in Table I .
The excretions of the tryptophan metabolites K, HK, HA, and XA and the various ratios for Cases 1 and 2, while they were receiving (a) normal dietary amounts of pyridoxine (approximately 1 mg./day) and (b) supplements of pyridoxine (30 mg./day) are given in Table II. The range of metabolite excretions and the mean values for the ratios in 13 control children are given in Table III .
Raised values of K/HA, XA/HA, and HK/HA, and normal values of K/HK were found when the patients were receiving normal dietary amounts of pyridoxine. Normal values for the metabolite excretions and ratios were observed when the patients were retested after receiving the oral pyridoxine supplements for periods varying from 1 week to 1 year 8 months. 654 Heeley, McCubbing, and Shepherd 4-2 2-7 1-7 1-7 2-7 1-6 1 yr. 8 mth. Table II . QA was measured in the 8-hour urines of (a) both the patients when they were receiving both normal dietary amounts and oral supplements ofpyridoxine, (b) 8 control children when they were receiving normal dietary amounts of pyridoxine, (c) 2 mentally defective children with convulsions who metabolized the tryptophan load abnormally (raised HK/HA and XA/HA) but who had normal serum amino acid patterns, and (d) 2 phenylketonuric children who were receiving normal diets and whose serum phenylalanine levels were greater than 15 mg./100 ml.
QA excretions, expressed as .moles/kg. body weight per 8 hr., for the sibs, L.H. and S.H., and the control subjects (mean ± SD) are given in Table IV. group 2-7 i 0 6 0 9 i 0-4 2 30
1-8 i 0-6* 2-2 ± 0 7 0 9 ± 0-3 1 30 1-3 + 0 3* 2-2 ± 0-2 0-8 ± 0-2 * 1 mg. is the approximate amount of pyridoxine in a normal diet. t Mean ± SD.
* Mean ± SD of 13 estimations while receiving pyridoxine supplements for periods varying from 1 week to 1 year 8 months.
The QA excretions in both the sibs were greater when they were receiving normal amounts of pyridoxine than when they were receiving the pyridoxine supplements. The data were insufficient to demonstrate a significant difference between the QA excretions in the sibs and the control group when receiving normal dietary amounts of pyridoxine.
When the values for HK/HA were raised, the excretions of HA were decreased. It was likely, therefore, that the defect at the kynureninase step would reduce the amount of HA for further metabolism via QA. It seemed relevant, therefore, to express QA excretion as a ratio to the excretion of HA, the precursor in the metabolic pathway. Fig. 2 shows that (a) this ratio, QA/HA, was relatively constant for the control group, (b) the ratio for Cases 1 and 2 was grossly raised when they The values for the branched-chain amino acids (mg./100 ml. serum) in the two sibs and normal children are shown in Table V . When receiving normal dietary amounts of pyridoxine Cases 1 and 2 had slightly raised values for leucine and Case 2 also had raised values for valine. Isoleucine levels were within the normal range for both patients.
When the children were given pyridoxine supplements the serum levels of leucine and valine were found to be consistently within the normal range of values. The mean values (± SD) for 13 estimations of the serum amino acids when the patients were receiving extra pyridoxine are shown in Table V (1963) investigated the effect of the oral administration of leucine on tryptophan metabolism in humans. High serum levels of leucine resulted in an increased urinary excretion of QA. The finding of a decreased excretion of N-methyl-6-pyridone nicotinamide suggested that leucine inhibited an enzyme in the pathway, but neither the site nor the mechanism of the inhibition were determined. The serum leucine levels of the subjects investigated by Belavady et al. (1963) were not reported, but the size of oral leucine loads administered makes it likely that they were considerably greater than the levels in the two children reported here. The finding that increased QA excretion accompanied raised serum leucine levels in these children seemed to confirm the observations of Belavady et al. (1963) .
The identical biochemical and clinical findings in both sibs are suggestive of an inborn error of metabolism. Preliminary investigations have revealed that the mother of the children, but not the father, metabolizes a tryptophan load abnormally with raised values for HK/HA. In early life it is probable that the endogenous synthesis of nicotinic acid is the major source of nicotinamide co-enzymes, a diminished supply of which might be expected to have a damaging effect on the developing nervous system. In the two mentally retarded sibs studied, it was demonstrated that under the 'stress' of a tryptophan load, defects existed at two separate sites along the tryptophan-nicotinamide pathway. It is possible that such an impairment would lead to a decreased availability of co-enzymes required for energy-producing reactions during brain development.
Summary
Two mentally retarded sibs, a girl aged 5 years and a boy aged 3 years, are described. Both children were found to have slightly raised serum concentrations of leucine and the boy also had a raised serum concentration of valine. In both children, tryptophan loading studies revealed a disorder ofmetabolism which involved the pyridoxaldependent enzyme, kynureninase. The administration of oral pyridoxine supplements corrected the abnormality of tryptophan metabolism and reduced the raised serum levels of leucine found in both sibs, and of valine in the boy, to normal. The relation between the defects of tryptophan and branchedchain amino acid metabolism was demonstrated when quinolinic acid was measured in the urine both before and after the administration of pyridoxine. The possible relation between the biochemical and clinical findings is discussed.
Effect of Pyridoxine on Tryptoph Appendix
Methods and Materials Serum branched-chain amino acids. Serum branched-chain amino acids were separated and measured by the paper chromatographic technique previously described by Clayton, Moncrieff, Pampiglione, and Shepherd (1966) . The solvent system employed for the separation of these amino acids has been described by Work (1948) .
Tertiary amyl alcohol (200 ml.) was shaken with distilled water (200 ml.) in a separating funnel. The lower aqueous layer was run into the bottom of the chromatography tank and diethylamine (2 ml.) was added. The serum extracts were applied to the paper, dried, and allowed to equilibrate in the tank overnight at room temperature. The papers were then developed (descending solvent technique) in the water-saturated tertiary amyl alcohol for 56 hours.
Measurement of quinolinic acid in urine. Quinolinic acid was separated from other urinary compounds by ion exchange chromatography. The colorimetric estimation was based on decarboxylation (Henderson and Hirsch, 1949) followed by cleavage of the pyridine ring and condensation of the resulting glutaconic aldehyde with a primary aromatic amine (Waisman and Elvehjem, 1941) .
Analytical grade reagents were used throughout the procedure. Quinolinic acid (puriss) was obtained from Koch-Light Laboratories Ltd. Standard solutions of QA in water (40 mg./100 ml.) were stable at 50 C. for at least 4 weeks.
Method. Dowex 50 (H+) resin was prepared according to the method of Price (1954) . Dowex 1 (Cl-) was converted to the formate form by running 8 vol.) . Concentrated HC1 (0 -15 ml.) was added to the urine (3 * 0 ml.), diluted to 20 ml. with water, and passed through a column of Dowex 50 (H +) resin (3 cm. x 1 cm.). The effluent was collected and the column was then washed with water (5 ml.). In order to separate the precursors of the urinary pigments from QA, the effluent and washings were combined and passed through a column of Dowex 1 (-COOH) resin (3 cm. x 1 cm.). The column was washed with water and the effluent discarded. QA was eluted with 0-1 N-HC1 (30 ml.). The concentrated eluates did not react with cyanogen bromide/o-tolidine, and therefore did not contain nicotinic acid or nicotinamide.
The Dowex 1 eluate (30 ml.) was evaporated to dryness in a rotary evaporator at 550 C. and the residue dissolved in glacial acetic acid (2 0 ml.). An aliquot (1 -0 ml.) was heated at 1050 C. in a sealed glass tube for 3 hours. Under these conditions QA was reproducibly decarboxylated to the extent of 90%. On cooling, the solution was diluted with water, adjusted to pH 4-5 with 2N-NaOH, and made up to 25 ml. in a volumetric flask. A sample of this solution (2 0 ml.) was mixed with ethanol (3 * 0 ml.) followed by 40/o (w/v) aqueous cyanogen bromide (1-0 ml.) and o-tolidine (1-0 ml. 10% (w/v) in ethanol). Extinctions were measured at 465 m,u. after 25 minutes in 1 cm. cuvettes using a Hilger and Watts Uvispek spectrophotometer. Extinctions were linear within the experimental range of nicotinic acid (i.e. urinary QA) concentrations, and the reaction product at maximum colour development was stable for several minutes. A solution of glacial acetic acid -NaOH (pH 4 5) and cyanogen bromide/o-tolidine was used for the blank setting of the instrument.
Standard amounts of QA (40 pig) were added to urine samples (3 * 0 ml.) and carried through the entire procedure. Under these conditions the mean recovery of QA was 87% + 12% (SD).
